Franklin Biotechnology Discovery Fund

Fund Description

The fund seeks capital appreciation by investing at least 80% of its net assets in securities of biotechnology companies and discovery research firms including those involved in fields such as genomics, genetic engineering, and gene therapy, as well as health care, pharmaceuticals and agriculture.

Strategy Statement

"With the increasing demand for new medical treatments driving earnings growth, and many profitable firms to choose from, we believe now is an exciting time to invest in the biotechnology sector."

Evan McCulloch, CFA®

Management

Evan McCulloch, CFA

Evan McCulloch, CFA®

  • Joined Franklin Templeton in 1992
  • Managed Fund Since 1997
Wendy Lam, Ph.D

Wendy Lam, Ph.D

  • Joined Franklin Templeton in 2016
  • Managed Fund Since 2018
Steve Kornfeld, CFA

Steve Kornfeld, CFA®

  • Joined Franklin Templeton in 2001
  • Managed Fund Since 2015

You need Adobe Acrobat Reader 6.0 or higher to view and print PDF documents. Download a free version from Adobe's website.